MedTrace Logo

New Biomarkers in Heart- and Renal Failure

NCT02830464 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-10-27

No results posted yet for this study

Summary

In this study, prognostically relevant biomarkers for cardiovascular / renal insufficiencies will be clinically evaluated, to improve the course of assessment of such disease and to gain new insights into the typical course of congestive heart failure. This is a prerequisite to allow patients to appropriate treatment as soon as possible.

Conditions

Sponsors & Collaborators

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Alexander Schuh, Priv.-Doz. Dr.med. · University Hospital, Aachen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-04-30
Completion
2018-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02830464 on ClinicalTrials.gov